Deerfield, IL - Astellas Pharma announced that the US Food and Drug Administration (FDA) has approved conivaptan hydrochloride injection (Vaprisol), an arginine vasopressin antagonist, for the ...

Please provide your email address to receive an email when new articles are posted on . The FDA’s Cardiovascular and Renal Drugs Advisory Committee today did not recommend approval of lixivaptan for ...

TOKYO, March 2 (Reuters) - Astellas Pharma Inc. <4503.T>, Japan's third-largest drug maker, said on Friday U.S. health authorities had approved an additional use for its drug Vaprisol which is used to ...

As a general rule, the treatment of hyponatremia should be directed at the primary underlying disorder because such treatment might, in itself, correct the electrolyte imbalance. Thiazide diuretics ...

Hyponatremia: An Update on the Management of SIADH Therapeutic options for SIADH have been significantly enhanced with the introduction of specific vasopressin receptor antagonists HOW TO TAKE THE ...

The FDA has approved an intravenous drug for hospital patients suffering from potentially life-threateningly low sodium levels, the drug's manufacturer said Friday. Astellas Pharma US Inc. said it ...

VAPRISOL (conivaptan) 20mg/ampule by Astellas Pharma A premixed formulation of Vaprisol (conivaptan HCl injection, from Astellas) has been approved for the treatment of hospitalized patients with ...

CHICAGO, Oct. 27 ReachMD XM 157 announces a new "MedicalIndustry Feature of the Week" highlighting a vasopressin receptor antagonistand its effects on management of euvolemic and hypervolemic ...

VAPRISOL (conivaptan) 20mg/ampule by Astellas Pharma Vaprisol (conivaptan HCl, from Astellas Pharma) Premixed injection, an arginine vasopressin (AVP) receptor antagonist, is available for the ...

FDA Approves Astellas Pharma's Vaprisol for the Treatment of Hypervolemic Hyponatremia DEERFIELD, Ill., March 2 -- Astellas Pharma US, Inc. today announced that the U.S. Food and Drug Administration ...

The treatment of hyponatremia has largely consisted of identifying and treating the underlying cause, such as correcting volume depletion and eliminating any offending medications. In situations where ...